Vermillion & White Wealth Management Group, LLC Cardiff Oncology, Inc. Transaction History
Vermillion & White Wealth Management Group, LLC
- $136 Billion
- Q4 2024
A detailed history of Vermillion & White Wealth Management Group, LLC transactions in Cardiff Oncology, Inc. stock. As of the latest transaction made, Vermillion & White Wealth Management Group, LLC holds 500 shares of CRDF stock, worth $1,875. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 500
-0.0%
Holding current value
$1,875
Previous $1.34 Million
62.55%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding CRDF
# of Institutions
125Shares Held
25.3MCall Options Held
866KPut Options Held
203K-
Commodore Capital LP New York, NY5.38MShares$20.2 Million2.34% of portfolio
-
Black Rock Inc. New York, NY2.63MShares$9.86 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$8.57 Million0.0% of portfolio
-
Orbimed Advisors LLC San Diego, CA1.54MShares$5.77 Million0.18% of portfolio
-
Acorn Capital Advisors, LLC New York, NY1.44MShares$5.41 Million3.38% of portfolio
About Cardiff Oncology, Inc.
- Ticker CRDF
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,334,900
- Market Cap $163M
- Description
- Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...